Effluent, sludge and biosolids pose potential risk of COVID-19 for farmers and wastewater workers

In a recent peer-reviewed study, posted to the journal Geoscience Frontiers, researchers conducted a systematic meta-analysis on several studies that assessed the viral RNA load of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in effluents, sludge, and biosolids, and found that the prevalence of SARS-CoV-2 RNA is highest in sludge, followed by biosolids and effluent respectively.

The study also points to the inefficiency of currently deployed treatment systems in inactivating and removing the novel virus from the environmental waste, which could eventually pose a potential health concern to the vulnerable population such as wastewater workers that handle the wastewater or farmers who use such treated environmental material in their fields.

Therefore, the team suggests the use of adequate personal protective equipment for the wastewater workers and urges them to use caution while using the reclaimed water for use in rural settings.

Study: A safe haven of SARS-CoV-2 in the environment: prevalence and potential transmission risks in the effluent, sludge, and biosolids. Image Credit: Gameanna / Shutterstock

Study: A safe haven of SARS-CoV-2 in the environment: prevalence and potential transmission risks in the effluent, sludge, and biosolids. Image Credit: Gameanna / Shutterstock

How do the terms effluent, sludge and biosolids differ?

Effluent is the liquid part of the sewage that comes out of a sewage treatment plant or septic tank after the completion of a treatment process. Sewage treatment aims to remove the contaminants from sewage to make the residual material suitable for reuse or direct discharge to the surrounding environment.

Sludge is the settleable solid organic matter separated from the liquids (effluent) and created during the treatment of wastewater.

Biosolids are produced later once the sludge undergoes additional treatment and stabilization to remove pathogens and create a stable product that meets the applicable criteria for beneficial recycling.

Background

The existing precautionary measures towards handling and exposure to various environmental materials have suffered a significant paradigm shift with the emergence of the coronavirus disease 2019 (COVID-19) pandemic. Studies from several countries have reported the presence of SARS-CoV-2 or its RNA in the environmental materials, including the air and wastewater samples.

The complex organic matter present in sludge and biosolids is known to shield the SARS-CoV-2 against inactivation. However, despite being considered as potential reservoirs of SARS-CoV-2, sludge and biosolids as a health risk domain, have so far received lesser attention compared to the wastewater samples.

The knowledge of SARS-CoV-2 prevalence in the final outputs of the wastewater treatment plants that are expected to be free from the SARS-CoV-2 and other pathogens or at least reach a safe limit post appropriate treatment will help to assess the subsequent risk of transmission and infection for the wastewater workers, farmers, and other handlers of these environmental materials. The team, therefore, conducted the current meta-analysis to investigate the prevalence of SARS-CoV-2 in the effluent, sludge, and biosolids extracted from wastewaters.

Prevalence of SARS-CoV-2 RNA is highest in sludge, followed by biosolids and effluent

The statistical meta-analysis was performed on a total of 21 articles, comprising 11, 8, and 2 articles on effluent, sludge and biosolids, respectively, that met the final criteria established by the team.

Based on the meta-analysis, the prevalence of the SARS-CoV-2 RNA in the effluents, sludge and biosolids were calculated to be 27.51 (C.I. 95%, 6.14-48.89), 1012.25 (C.I. 95%, 104.78 -1019.71) and 30.59 (C.I. 95%, 10.10-51.08), respectively.

Biosolids, despite receiving further treatment, demonstrated higher SARS-CoV-2 RNA prevalence rates compared to that in the effluent. This indicates the ability of the viral particles to obtain protection for persistence in the solid medium.

SARS-CoV-2 viral envelope aids retention in sludge and biosolids

The hydrophobic nature of the viral envelope layer is responsible for affinity to adsorb to the solid particles present in sludge and biosolids, ensuring their survival in such materials if not subjected to advanced treatments. Solid particles as small as 0.3 mm have been demonstrated to shield the viruses from disinfection, thereby extending their persistence. Based on the observations of virus persistence in sludge, the team recommends the use of the sludge samples for the purpose of virus surveillance in the population.

Transmission and health risks associated with effluents, sludge, and biosolids

The long exposure to the raw or partially treated sewage sludge, such as during manual sludge handling, indicates a high risk of transmission to the wastewater handlers. Aerosols containing the viral particles, generated during the various steps of wastewater processing and during the application of effluents and sludge in the field, also pose a potential risk SARS-CoV-2 transmission to the wastewater workers and farmers.

Moreover, the direct application of inadequately or non-treated effluents, sludge, and/or biosolids to the soil and plant in some developing and low-income countries can result in virus migration to the subsurface system, groundwater, or uptake by the plants, thus leading to transmission via either direct contact or ingestion of contaminated water or crops.

“Adequate protections, including the use of personal protective equipment should be ensured for the wastewater/sludge workers, while the use of reclaimed wastewater and other materials like sludge and biosolids should be done with caution, especially in rural settings of developing and low-income countries where water, sanitation, and hygiene are insufficiently deployed”, advises the team.

The group of people who are most vulnerable to exposure risk are wastewater workers, farmers and their families, consumers of farm produce, and residents in the areas irrigated with wastewater, especially children, aged people, and immunocompromised individuals

Although the reuse of effluent, sludge, and biosolids can efficiently address the issue of perennial water scarcity in many countries, enhance nutrient recycling, improve soil health, mitigate the direct discharge of wastewater into water-bodies, these environmental materials need to be carefully managed to prevent the associated public health risks.

“The current treatment processes alongside the guidelines on the use of environmental materials like effluent, sludge, and biosolids should be revisited and improved upon to efficiently address the recalcitrant nature of SARS-CoV-2 RNA and other emerging pathogens.”, recommends the team.

The team also emphasizes executing further studies on estimating the prevalence of infectious SARS-CoV-2 particles in the environmental materials. The demonstration of genetic material/RNA does not imply the viability or infectiousness of the virus and health implications ingesting SARS-CoV-2 RNA are lacking.

Journal reference:
Namita Mitra

Written by

Namita Mitra

After earning a bachelor’s degree in Veterinary Sciences and Animal Health  (BVSc) in 2013, Namita went on to pursue a Master of Veterinary Microbiology from GADVASU, India. Her Master’s research on the molecular and histopathological diagnosis of avian oncogenic viruses in poultry brought her two national awards. In 2013, she was conferred a doctoral degree in Animal Biotechnology that concluded with her research findings on expression profiling of apoptosis-associated genes in canine mammary tumors. Right after her graduation, Namita worked as Assistant Professor of Animal Biotechnology and taught the courses of Animal Cell Culture, Animal Genetic Engineering, and Molecular Immunology.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Namita Mitra, Namita Mitra. (2022, February 25). Effluent, sludge and biosolids pose potential risk of COVID-19 for farmers and wastewater workers. News-Medical. Retrieved on October 05, 2024 from https://www.news-medical.net/news/20220225/Effluent-sludge-and-biosolids-pose-potential-risk-of-COVID-19-for-farmers-and-wastewater-workers.aspx.

  • MLA

    Namita Mitra, Namita Mitra. "Effluent, sludge and biosolids pose potential risk of COVID-19 for farmers and wastewater workers". News-Medical. 05 October 2024. <https://www.news-medical.net/news/20220225/Effluent-sludge-and-biosolids-pose-potential-risk-of-COVID-19-for-farmers-and-wastewater-workers.aspx>.

  • Chicago

    Namita Mitra, Namita Mitra. "Effluent, sludge and biosolids pose potential risk of COVID-19 for farmers and wastewater workers". News-Medical. https://www.news-medical.net/news/20220225/Effluent-sludge-and-biosolids-pose-potential-risk-of-COVID-19-for-farmers-and-wastewater-workers.aspx. (accessed October 05, 2024).

  • Harvard

    Namita Mitra, Namita Mitra. 2022. Effluent, sludge and biosolids pose potential risk of COVID-19 for farmers and wastewater workers. News-Medical, viewed 05 October 2024, https://www.news-medical.net/news/20220225/Effluent-sludge-and-biosolids-pose-potential-risk-of-COVID-19-for-farmers-and-wastewater-workers.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cardiovascular risks post-COVID-19 vaccination: Key findings